Are you searching for therapy options for your chronic stroke patients? View this webinar and learn how the FDA-approved Vivistim® can help increase neuroplasticity for improved hand and arm function.


Amanda Saylor, OTR/L, CNS, CBIS, a Vivistim Therapist at AdventHealth in Orlando, FL, presents the outcomes of more than 12 chronic ischemic stroke patients who participated in Vivistim Therapy to help improve their upper extremity motor function.


Topics of discussion include:
  • Overview of Vivistim Therapy
  • In-clinic and at-home Vivistim Therapy protocol
  • Results following the initial 6 weeks of Vivistim Therapy
  • Longer-term outcomes beyond 6 weeks
  • Live Q&A

Don't miss this opportunity to discover how Vivistim Therapy™ can help make stroke rehabilitation more effective for your patients.

Please note, this webinar is for healthcare professionals only.

Guest Speaker:

 

 

Amanda Saylor, OTR/L, CNS, CBIS
Divisional Occupational Therapy Lead
AdventHealth Sports Med & Rehab
Orlando, FL

 

Watch On-Demand Now 

 
 

The MicroTransponder® Vivistim® Paired VNS™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if the patient has had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. Infection leading to explant is a risk associated with any device. Individual results may vary. 
 
©2024 MicroTransponder Inc. All rights reserved.  Vivistim, Vivistim Therapy and Paired VNS are trademarks of MicroTransponder Inc.